Florida, February 06.2018: The scope of the report includes a detailed study of global and regional markets for Global Preclinical Imaging In-VIVO Systems and Reagents Market with the reasons given for variations in the growth of the industry in certain regions.

    The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report include Aspect Imaging Ltd, Bruker Corporation, Fujifilm Holdings Corporation, Li-Cor Biosciences, MR Solutions Ltd., Mediso Ltd., Milabs B.V., MiltenyiBiotec GmbH, Perkinelmer and Trifoil Imaging. Company profile includes assign such as company summary, financial summary, business strategy and planning, SWOT analysis and current developments.

    The   preclinical imaging in vivo systems and reagents Market is expected to exceed more than US $ 960 million by 2022 and will grow at a CAGR of more than 6% in the given forecast period.

    Browse Full Report: https://www.marketresearchengine.com/reportdetails/preclinical-imaging-in-vivo-systems-and-reagents-market

    This report provides:

    1) An overview of the global market for Global Preclinical Imaging In-VIVO Systems and Reagents Market and related technologies.
    2) Analyses of global market trends, with data from 2013, estimates for 2014 and 2015, and projections of compound annual growth rates (CAGRs) through 2022.
    3) Identifications of new market opportunities and targeted promotional plans for Global Preclinical Imaging in Vivo Systems and Reagents Market.
    4) Discussion of research and development, and the demand for new products and new applications.
    5) Comprehensive company profiles of major players in the industry.

    The major driving factors of Global Preclinical Imaging IN-VIVO Systems and Reagents Market are as follows:

    •    Technical advancements in the area of molecular imaging
    •    Growing market demand for noninvasive small animal imaging techniques
    •    Increasing number of public and private initiative and financial support to support preclinical researches

    The restraining factors of Global Preclinical Imaging In-VIVO Systems and Reagents Market are as follows:

    •    Strict rules leading preclinical research
    •    Major installation and operational cost related with preclinical

    Request Sample Report: https://www.marketresearchengine.com/requestsample/preclinical-imaging-in-vivo-systems-and-reagents-market

    Table of Contents


    2 Research Methodology

    3 Executive Summary

    4 Premium Insights

    5 Preclinical Imaging Market Overview

    6 Industry Insights

    7 Global Preclinical Imaging Market, By Modality

    7.1 Introduction
    7.2 Optical Imaging Systems
    7.2.1 Bioluminescence/Fluorescence Imaging Systems
    7.2.2 Standalone Fluorescence Imaging Systems
    7.2.3 (Optical + X-Ray)/(Optical + CT) Systems
    7.3 Nuclear Imaging Systems
    7.3.1 Micro-PET Systems Standalone PET Systems PET/CT Systems PET/MRI Systems
    7.3.2 Micro-Spect Systems Standalone Spect Systems Spect/CT Systems Spect/MRI Systems
    7.3.3 Trimodality (Spect/PET/CT) Systems
    7.4 Micro-MRI
    7.5 Micro-Ultrasound
    7.6 Micro-CT
    7.7 Photoacoustic Imaging Systems
    7.8 Magnetic Particle Imaging (MPI) Systems

    8 Global Preclinical Imaging Market, By Reagent

    9 Preclinical Imaging Market, By Region

    10 Competitive Landscape

    11 Company Profiles

    11.1 Introduction

    11.2 Perkinelmer, Inc.

    11.3 Bruker Corporation

    11.4 Fujifilm Holdings Corporation

    11.5 Mediso Ltd.

    11.6 Milabs B.V.

    11.7 MR Solutions Ltd.

    11.8 Aspect Imaging Ltd.

    11.9 Li-Cor Biosciences

    11.10 Trifoil Imaging

    11.11 Miltenyi Biotec GmbH

    Media Contact

    Company Name: Market Research Engine

    Contact Person: John Bay

    Email: john@marketresearchengine.com

    Phone: +1-855-984-1862, +91-860-565-7204

    Country: United States

    Website: https://www.marketresearchengine.com/


    Source: http://www.financeswire.comglobal-preclinical-imaging-in-vivo-systems-and-reagents-market-is-expected-to-get-us-960-million-by-2024